HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
发明人:
Abraham Rutenberg,Ronny Uzana,Michal Lotem,Arthur Machlenkin,Galit Eisenberg,Tamar Peretz-Yablonsky,Shoshana Frankenburg,Roni Engelstein
申请号：
US15110111
公开号：
US10344073B2
申请日:
2015.01.08
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Provided is directed to the field of immunotherapy. Specifically, provided are compositions and methods for improved T cell modulation ex vivo and in vivo and for the treatment of cancer and other pathologies. More specifically, embodiments of the subject matter are directed to the use of soluble NTB-A polypeptides or agonists thereof for the treatment of cancer patients, for preventing and treating cytopenia in susceptible patients, and for the ex vivo preparation of improved cell compositions.
